Literature DB >> 28576643

Heel pain in psoriatic arthropathy: Analysis of a series of 291 patients.

Isabel Morales Ivorra1, Pablo Juárez López1, Mercè López de Recalde1, Pedro David Carvalho2, Jesus Rodriguez Moreno3.   

Abstract

OBJECTIVE: To determine the prevalence of heel pain in a series of patients with psoriatic arthritis (PsA).
MATERIAL AND METHODS: Cross-sectional, observational and retrospective study of a series of 347 patients. All patients fulfilled the CASPAR criteria for PsA and 291 had a clinically significant history of heel pain. The statistical analysis was performed using chi-square test, ANOVA and binary logistic regression.
RESULTS: Thirty-five percent of the patients had clinically significant heel pain. A significant association was established between an early onset of skin and joint involvement in the disease and the development of heel pain. However, no significant correlation was found between disease duration and the presence of heel pain. History of dactylitis and PsA in first-degree family members was also statistically associated with this complication.
CONCLUSIONS: Clinically significant heel pain was recorded in one third of the patients in this series. There was a statistically significant association with dactylitis, PsA in first-degree family members and an earlier onset of joint and skin disease.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Artritis psoriásica; Dolor; Entesopatía; Enthesopathy; Heel; Pain; Psoriasis; Psoriatic arthritis; Talón

Mesh:

Year:  2017        PMID: 28576643     DOI: 10.1016/j.reuma.2017.03.010

Source DB:  PubMed          Journal:  Reumatol Clin (Engl Ed)        ISSN: 2173-5743


  1 in total

1.  Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.

Authors:  Frank Behrens; Philipp Sewerin; Eugenio de Miguel; Yusuf Patel; Anastas Batalov; Eva Dokoupilova; Christine Kleinmond; Effie Pournara; Ankita Shekhawat; Claudia Jentzsch; Annette Wiedon; Xenofon Baraliakos
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.